QGP Short: AI in GMP Environments - Risks and Regulatory Guidance
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
About this listen
Send us a text
In pharmaceutical and biotech manufacturing, artificial intelligence is no longer a future concept. It’s here, supporting product development, process control, and quality decisions in GMP-regulated environments. But with this opportunity comes significant responsibility. While AI offers powerful capabilities, it also introduces a new set of risks, ones that must be managed to meet compliance, safety, and quality expectations.
In this Quality Grind Short - Mike outlines both the risks and opportunities that AI provides, and highlights guidance being provided by global regulatory agencies.
Contact MEDVACON:
- Message us at @MedvaconLifeSciences on LinkedIn
- Visit our website at www.medvacon.com/contact
- Email us at qualitygrind@medvacon.com
Thanks for listening! Don't forget to follow us @medvacon on all platforms for updates on blogs and podcasts!
No reviews yet